BioRestorative Therapies, Inc. BRTX

Set alert

Price alert · BRTX

All alert types
1.51 USD +0.03 +2.03%

As of Nov 3, 10:38 AM ET

Bid
1.48 × 30
Ask
1.58 × 2
1.50 Day range 1.51
1.28 52-week range 30.17
YTD
+29.06%
1 year
+0.67%
Open
1.50
Prev close
1.48
Mkt cap
2.09M
Vol
8.42K
Avg vol
29.46K
EPS
-21.40
P/E
0.00
Div yield
0.00%
More statistics
Low
1.50
High
1.51
Forward P/E
-0.90
Beta
0.00
Short ratio
1.95
Inst. own
13.74%
Dividend
0.00
Ex-div date
Earnings
Mar 24, 2023
50-d avg
1.54
200-d avg
1.53
1y target
13.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BRTX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 13.00 +760.9% upside
Target (low)
8.00
Target (mean)
13.00
Target (high)
18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BRTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.27-0.27 – -0.27-0.57+52.6%475.00K+2361.1%1
Next quarter-0.26-0.26 – -0.26-0.5898+55.9%628.00K+1694.3%1
Current year0.000.00 – 0.000.000.0%833.00K+471.3%0
Next year-0.86-0.86 – -0.860.000.0%2.60M+212.2%1

Upgrades and downgrades

The latest rating changes

BRTX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 14, 2024Roth MKMMaintainedBuyBuy
Jun 12, 2024Roth MKMMaintainedBuyBuy
Aug 14, 2023Roth MKMReiteratedBuyBuy
Dec 7, 2022Roth CapitalInitiated—Buy
Sep 28, 2022Maxim GroupInitiated—Buy
Dec 1, 2021Roth CapitalInitiated—Buy